- Home
- OPK
OPK
OPKO Health Inc.
as 10-22-2024 4:00pm EST
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 1.0B | IPO Year: | 1995 |
| Target Price: | $2.75 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.85 - $1.75 | Next Earning Date: | 11-04-2024 |
| Revenue: | $716,372,000 | Revenue Growth: | -17.48% |
| Revenue Growth (this year): | -17.51% | Revenue Growth (next year): | 1.36% |
Stock Insider Trading Activity of OPKO Health Inc. (OPK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| OPKO HEALTH, INC. | OPK | 10% Owner | Aug 15 '24 | Sell | $33.96 | 139,824 | $4,756,875.36 | 2,746,972 | |
| OPKO HEALTH, INC. | OPK | 10% Owner | Aug 12 '24 | Sell | $34.35 | 84,774 | $2,898,313.64 | 2,746,972 | |
| OPKO HEALTH, INC. | OPK | 10% Owner | Aug 6 '24 | Sell | $30.59 | 112,994 | $3,563,807.18 | 2,746,972 | |
| OPKO HEALTH, INC. | OPK | 10% Owner | Jul 31 '24 | Sell | $33.50 | 88,839 | $2,976,346.37 | 2,746,972 | |
| OPKO HEALTH, INC. | OPK | 10% Owner | Jul 29 '24 | Sell | $33.86 | 50,000 | $1,692,890.00 | 2,746,972 |
Latest OPKO Health Inc. News
OPK Breaking Stock News: Dive into OPK Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
With 50% ownership, OPKO Health, Inc. (NASDAQ:OPK) insiders have a lot riding on the company's future
Zacks
12 days ago
OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies
MT Newswires
16 days ago
NextPlat's E-Commerce Agreement with OPKO Health Extended in China, Expanded Into Japan
MT Newswires
16 days ago
OPKO Health's ModeX Receives $35 Million in Federal Funding for Covid, Flu Vaccine Development
GlobeNewswire
16 days ago
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
PR Newswire
16 days ago
NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan
Zacks
21 days ago
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
Zacks
a month ago
ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
Compare OPK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPK OPKO Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.